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ABSTRACT
Buffaloes are compulsory vaccinated against foot-and-mouth disease virus (FMDV) in many countries as
part of the official control programmes. Serological testing aimed to indirectly assess herd immunity is
currently performed using the same Enzyme-linked immunosorbent assays (ELISAs) applied for bovine
sera, assuming an agreement between the ELISA’s diagnostic results and those obtained using the
virus neutralization test (VNT). Here we evaluated the accuracy of different ELISA tests to assess
vaccine-induced antibodies against FMDV in buffalo’s sera classified according to their VNT titres.
Currently used liquid-phase blocking ELISA yielded very low specificity, producing high titres for many
samples with low VNT titres. To increase specificity, we developed an indirect ELISA using purified 140S
viral particles and an avidity single-dilution ELISA, which includes a urea washing step after the
incubation of the diluted serum sample, to detach weak binders. Combining these two high-
throughput single-dilution tests, an excellent concordance with VNT was achieved. This is the first
study analysing the diagnostic agreement of traditional and novel serological tests with VNT for the
indirect assessment of antibodies against FMDV capsid proteins in buffalo serum samples.
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Foot-and-mouth disease (FMD) is an acute, highly contagious
viral disease that affects a wide range of hosts, including buffa-
loes (Grubman & Baxt 2004; OIE 2012), and is distributed world-
wide. Argentina is free of the disease, with a northern region
under vaccination programmes and a southern region, Patago-
nia, free of vaccination. Bovines and buffaloes older than 2 years
of age are vaccinated once a year, while immunizations are
performed every six months to calves aged up to 2 years
old (SENASA 2013). The current vaccine in Argentina is oil-adju-
vanted and contains four foot-and-mouth disease virus (FMDV)
strains.
Water buffalo (Bubalus bubalis) population in Argentina is
exceeding 100,000 heads, which is the third largest population
in America, after Brazil and Venezuela. Buffaloes are located in
the north-east of the country within the FMD vaccination terri-
tories (Crudeli 2014) and in neighbouring areas close to the
border with Paraguay, where the latest regional FMDV-type O
outbreak occurred in 2011 (Maradei et al. 2013; Brito et al.
2015). The role of African buffalo (Syncerus caffer) in the epide-
miology of the disease is well documented (Dawe et al. 1994;
Weaver et al. 2013; Knight-Jones et al. 2016), but the behaviour
of FMDV in water buffaloes, which are domesticated in several
areas of the world, has been less studied. FMDV transmission
between cattle and water buffaloes has been observed in
natural outbreaks (Dutta et al. 1983; Samara & Pinto 1983)
and in experimental studies (Gomes et al. 1997; Maroudam
et al. 2008). A recent study demonstrated that Indian buffaloes
(Bubalus bubalis) have the potential to spread FMD by direct
contact to naïve susceptible animals (Madhanmohan et al.
2014). In this context, the accurate assessment of immunity
induced by compulsory vaccination of buffaloes is paramount.
According to the World Organization for Animal Health (OIE),
the virus neutralization test (VNT) is considered as the ‘gold
standard’ for the detection of antibodies reactive to FMDV
structural proteins (OIE 2012). Liquid-phase blocking ELISA
(LPBE) and VNT results have been used to develop tables that
relate the serological titres of vaccinated cattle to the prob-
ability of protection, called the ‘expected percentage of protec-
tion’ (EPP). EPP estimates the likelihood that cattle would be
protected against a challenge after vaccination (OIE 2012). In
South America, a cut-off of a 75% (EPP-75%) is used to estimate
protective vaccine-induced responses, statistically predicted
from challenge experiments in cattle, using either VNT or
LPBE titres. These cuts-off values are considered when assessing
herd immunity (Maradei et al. 2008; Robiolo et al. 2010b).
LPBE entails the use of standardized capture (rabbit) and
detection antibodies, either a mix of monoclonal antibodies
(LPBE-Mab) or hyperimmune guinea-pig sera (LPBE-HIS). LPBE
has been validated for bovine samples, as being as reliable
and precise as the VNT (Robiolo et al. 1995; Maradei et al.
2008; Robiolo et al. 2010b) and is routinely used to assess
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herd immunity (Leon et al. 2014). A single-dilution LPBE-Mab
has also been validated for the four vaccine strains included
in the Argentinean commercial vaccine (Robiolo et al. 2010a).
It has been demonstrated that the kinetics of neutralizing
responses against FMDV in cattle and buffaloes is similar
(Gomes et al. 1997; Maddur et al. 2009), but concordance
between VNT and LPBE has not been assessed for buffalo
serum samples. Moreover, information on the protective VNT
or LPBE titres following a challenge in buffaloes is not available.
VNT is a time-consuming assay that requires the manipu-
lation of live virus and cell culture, and it is difficult to standar-
dize and set-up. In vitro neutralizing activity usually correlates
with avidity (Bachmann et al. 1997) which can be easily
measured by ELISA. Correlation between avidity and VNT has
been reported for vesicular stomatitis virus (Bachmann et al.
1997), measles virus (Saika et al. 2008), tick-borne encephalitis
(Leonova & Pavlenko 2009) and bovine viral diarrhoea virus
(Franco Mahecha et al. 2011). We have also shown that the
avidity indexes of anti-FMDV bovine antibodies are concordant
with the VNT results (Lavoria et al. 2012; Brito et al. 2014).
Here we set-up a high-throughput single-dilution avidity
ELISA (AE) together with an indirect ELISA (IE) for buffalo
samples that use purified virus as capture antigen and do not
require detection antibodies. The aim of this study was to evalu-
ate the diagnostic agreement of traditional and novel ELISAs
with VNT, to be applied for the indirect assessment of herd
immunity against FMDV using buffalo serum samples.
2. Materials and methods
2.1. Serum samples
Serum samples (n = 91) were collected from two water buffalo
herds (Mediterranean breed) placed in different areas of the
province of Corrientes, Argentina. Samples were selected to
comprise all the spectrum of neutralizing antibody levels. One
herd was sampled on 5th November 2013, 5 days post-vacci-
nation. It consisted of 43 animals, of which 25 were adult
females over 3 years old, which had received at least 3 vacci-
nations within the official vaccine FMD programme (last one
in November 2012). The other 18 animals were calves
between 5 and 6 months of age with VNT titres below detection
levels (Log10 titre≤ 1). The other herd consisted of 48 animals:
33 adult vaccinated males and females (over 3 years old) that
had received at least 3 vaccinations (last one in November
2012) and 15 naïve non-vaccinated calves or steers, between
7 and 12 months old, with VNT titres below detection levels
(Log10 titre≤ 1). Samples were taken on November 7th, 2013,
22 days before the corresponding vaccination campaign.
Blood samples were obtained from the jugular vein using
sterile needles and syringes, placed in glass tubes (10 ml) and
centrifuged at 1000 rpm for 15 min to recover serum. The
samples were aliquoted in six 0.5 mL fractions and preserved
at −20°C until processing. All samples tested negative for
non-structural proteins by the PrioCHECK® FMDV NS Antibody
ELISA Kit (ThermoFisher Scientific), performed following the
manufacturer`s instructions.
A positive control was generated by pooling 10 buffalo
serum samples from animals with more than 5 vaccinations,
with VNT and LPBE titres over Log10 = 4. A negative pool of n
= 10 samples with individual titres below Log10 = 1 was used
as negative plate control. These samples individually and
pooled were used to estimate the intermediate precision (see
below) of the IEs.
2.2. Vaccine
Animals had been immunized as part of the national control
programme with an officially approved commercial tetravalent
single-oil emulsion vaccine, free of non-structural proteins, con-
taining four inactivated FMDV strains: O1/Campos/Brazil/58
(O1/Campos), A24 Cruzeiro/Brazil/55 (A24/Cruzeiro), A/Argen-
tina/2001 (A/Arg/01) and C3/Indaial/Brazil/71 (C3/Indaial)
(SENASA 2006b, 2013). This vaccine induced LPBE antibody
titres compatible with an EPP-75% measured at 60 dpv for
each strain, according to the national sanitary authority
(SENASA) regulations (SENASA 2006a; SENASA 2010). The
vaccine was applied intramuscularly in the side of the neck
(2 mL/dose) according to the manufacturer’s recommendations
and official regulations (SENASA 2010).
2.3. Serology
Serology was performed using the O1/Campos vaccine strain
provided by SENASA. This strain was selected because the
latest regional outbreaks were caused by O strains (Brito et al.
2015).
2.3.1. Neutralization assay
Serum neutralizing antibodies were titrated by a conventional
VNT using infective culture-adapted FMDV O1/Campos strain.
Virus titer was 107 TCID50/ml (Tissue Culture Infectious Dose
50%) on Baby Hamster Kidney cell line, as described in the
OIE Manual of Diagnostic Tests and Vaccines for Terrestrial
Animals and adapted by Bucafusco et al. (OIE 2012; Bucafusco
et al. 2014). The endpoint titres of the serum samples were
expressed as the logarithm (Log10) of the reciprocal of the last
dilution of serum that neutralized 100 × TCID50 of the virus in
50% of the wells.
The EPP was used to estimate and quantify protective
vaccine-induced responses. The EPP represents the correlation
between bovine antibody titres at 60 days post-vaccination
(dpv), measured by LPBE or VNT, and the percentages of protec-
tion achieved for the same groups of animals after in vivo chal-
lenge experiments, performed at 90 dpv following the
‘protection against generalized foot infection test’ (OIE 2012).
The titre corresponding to EPP-75% for the FMDV O1/Campos
strain is 1.65 for VNT.
2.3.2. Liquid-phase blocking ELISAs
Total anti-FMDV O1/Campos antibody responses were
assessed by LPBE, performed as stated in the OIE Manual
(OIE 2012), using two different detector antibodies: a guinea-
pig anti-FMDV O1/Campos hyperimmune sera (LPBE-HIS)
(Bucafusco et al. 2014), or a cocktail of strain-specific mono-
clonal antibodies (LPBE-Mab) (Robiolo et al. 1995; Robiolo
et al. 2010b). Both LPBEs use a rabbit antiserum to capture
the virus and an inactivated O1/Campos preparation from
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clarified-infected cell cultures (kindly provided by a local
vaccine producer). The serum samples were incubated with a
standardized dilution of inactivated virus, and free (unbound)
virus was revealed using the corresponding detector antibody
preparation. Antibody titres were expressed as the reciprocal
log10 of serum dilutions, giving 50% of the absorbance
recorded in the virus control wells without serum. The titre cor-
responding to EPP-75% for the FMDV O1/Campos strain is
Log10= 2.11 for LPBE using bovine serum samples (Maradei
et al. 2008). Both LPBEs are used for assesing vaccine efficacy
(SENASA 2010).
2.3.3. Single-dilution total antibody and AE
Avidity assessment of specific antibodies was performed as
described by Lavoria et al. (2012) and adapted for buffalo
serum samples. Briefly, purified-inactivated O1/Campos 140S
particles were used as capture antigen. Whole viral particles
were obtained by 15–45% sucrose density gradient centrifu-
gation (Barteling & Meloen 1974) optimized in our laboratory
(Pega et al. 2013). The test entails a single dilution of the
sample (1:50) and the presence of antibodies is expressed as
OD values either after a regular PBS wash (for indirect ELISA,
“IE”) or by adding a urea washing step (AE). The IE assesses
total antibodies, while the AE is an assay including a urea
washing step to detach low avidity binders.
2.4. Data acquisition
Buffalo serum samples were tested for neutralizing antibodies
against O1/Campos strain and classified according to their
titres: 27 had VNT titres below 1.65 (Log10 titre) for O1/
Campos strain and 64 were above this value. The samples
were then tested by two standard LPBEs and by a single-
dilution ELISA to assess total antibodies (IE). The avidity of
these specific antibodies was measured by the IE by adding a
washing step with a chaotropic agent after incubating the
serum sample, aimed to detach low-binding antibodies (AE).
The results obtained by all these ELISAs were compared to
VNT titres to evaluate their concordance with this test in pre-
dicting a protective status.
2.5. Statistical analysis
Serological assays were performed blinded to the results of the
other tests and were then compared all together. VNT titres
were used as a gold standard to classify antibody levels
related to the VNT EPP-75% for the FMDV O1/Campos strain
(Log10= 1.65).
Receiver operator characteristic (ROC) curves (Greiner et al.
2000) using O1/Campos LPBE titres, IE and AE OD values com-
puted with VNT titres were constructed. The area under the
curve (AUC) was calculated and tested for statistical signifi-
cance. The sensitivity (Se), specificity (Sp) and accuracy of the
dichotomized test results were determined by the optimal
AUC value in the ROC curves for results obtained with LPBE-
Mab, LPBE-HIS, IE and AE.
Correlation between the different tests was assessed using
Pearson’s correlation analysis (Pearson’s r value) with a 95%
confidence interval (CI). Linear regression was applied to
compare both LPBEs, and also ELISA results with VNT titres.
Goodness of fit was estimated by the r2 value and a runs test
was used to calculate deviation from linearity. Intermediate pre-
cision was estimated by computing the coefficient of variations
of values obtained with the 20 positive control samples and 15
negative samples run by two different operators using the same
measurement procedure, and replicate measurements
obtained over an extended period of time, repeated with
three different reagent lots. The results were compared by
ANOVA 2-factor repeated measures followed by a Bonferroni
multiple comparisons test. The CI was 95%. These analyses
were carried out using GraphPad Prism v5.0 (GraphPad
Software).
To determine the pair-wise level of agreement between
results obtained by the different ELISAs and VNT, we computed
Cohen’s Kappa (κ) value and its 95% CIs. The level of agreement
was interpreted according to κ value as none (0.0–0.2), minimal
(0.21–0.39), weak (0.40–0.59), moderate (0.60–0.79), strong
(0.80–0.90) or excellent (above 0.91) (McHugh 2012).
To optimize diagnostic accuracy, the Se and Sp of all possible
2-test combinations were also estimated (using MedCalc soft-
ware Version 16.8). We exercised a sequential evaluation
meant to augment the overall specificity: the samples were
first run using one of the high-sensitive tests (called ‘T1’), nega-
tive results were accepted and those samples with values above
the T1 cut-off were retested using a high specific assay (T2).
We computed ROC curves, AUC values, CI, correlation and
cut-off test values aimed to maximize accuracy in terms of Se
and Sp using ROCR package in R. (Sing et al. 2005). An online
calculator was used to obtain the κ value (http://analyse-it.
com/docs/220/method_evaluation/qualitative.htm).
3. Results
3.1. Performance of the ELISAs with buffalo serum
samples
In order to verify the correct performance of the IEs with buffalo
serum samples, we estimated the intra-plate and intra-day
repeatability of both IEs. The intra-laboratory repeatability
(intermediate precision) was estimated with results obtained
Figure 1. Individual LPBE titres (log scale) against O1/Campos measured by LPBE-
HIS or LPBE-Mab were plotted to study the concordance between both tests.
Dotted lines indicate the cut-off value for EPP-75%. Open squares correspond to
three samples classified correctly by LPBE-HIS and open circles correspond to
those classified correctly by LPBE-Mab. VNT titres of outliers are indicated above
each tick.
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by two different technicians, using three replicates of 10 samples
with high VNT titres against the O1/Campos strain. The samples
were run on three different days, using three different reagent
batches. Coefficients of variation for positive control samples
were below 10% for all the operators for both assays. No signifi-
cant differences were found between mean IE and AE intra- or
inter-plate OD values (p > 0.05). ANOVA analysis showed there
were no differences in the OD values due to the operator, the
urea treatment or the reagent lot used (p = 0.45, 0.54 and 0.84,
respectively). For IE, no significant differences in OD were
found due to the operator or reagent lot (p > 0.05).
We then analysed if both LPBEs (Mab and HIS) performed
equally, as they do for bovine serum samples. The titres
obtained in both assays were plotted. LPBE-Mab and LPBE-HIS
gave concordant results (Figure 1) with significant correlation
(Pearson’s r = 0.8041, CI 0.7154–0.8675; p < .0001). Only five
non-concordant results were found between both LPBE tests.
Virus neutralization titres of these samples indicated that
three of them were classified correctly by LPBE-HIS and the
other two samples were correctly categorized by LPBE-Mab.
VNT titres of outliers are shown in Figure 1.
3.2. Comparative agreement between ELISAs and VNT
diagnostic results
In order to assess the sensitivity and specificity of the novel tests
using buffalo’s serum samples, ROC curves were built (Figure 2)
using LPBE titres or ODvalues (for IE andAE). The values obtained
for the AUC for each ELISA indicated that the four tests were
accurate and useful to classify buffalo serum samples. The
values were very good for LPBE (LPBE-HIS: AUC = 0.82; LPBE-
Mab AUC = 0.76) and excellent for IE and AE (AUC: 0.92 and
0.97, respectively). For all the tests, the overall sensitivity and
specificity were determined by using the cut-off value, giving
the best diagnostic performance. Sensitivity was about 84% for
both LPBEs, but specificity was low (∼ 48%; Table 1). The cut-
off values were OD = 0.99 for IE and OD = 0.7 for AE. These
assays yielded an overall result of good sensitivity (71.2% for IE
and 74.6% for AE) and very good specificity. The highest speci-
ficity value was achieved by the AE (93.8%; Table 1).
A weak agreement was found between the four ELISAs and
VNT; although correlation was significant (p < 0.05), Pearson’s r
values were low for the four assays (Table 2). Concordance
between VNT and the ELISAs was assessed by computing the
Kappa value. Only AE showed a weak agreement with VNT
results (κ = 0.62, Table 1), while the other assays yielded only
a minimal agreement (κ = 0.35).
3.3. Optimizing the diagnostic accuracy of the
serological tests
The pattern of relative frequency distribution of different values
organized by range was then analysed. The results are shown in
Figure 3. The frequency graph shows that AE classified correctly
85% of the samples with VNT titres below Log10 = 1.65, most of
them with low OD values (<0.3). However, about 50% of the
positive values were found in an OD range coincident with
36% of the negative samples. These samples had VNT titres
close to the cut-off value. Most of the positive samples were
classified correctly by IE as 78% of the samples with VNT titres
above Log10 = 1.65 gave OD values >1. The graphs also
showed that LPBE-HIS and LPBE-Mab were good in identifying
high positive samples, with VNT titres over Log10 = 3.
However, negative samples were distributed with a similar fre-
quency among all the titre ranges.
Since LPBEs’ assessment yielded low specificity when using
buffalo samples, we exercised a sequential evaluation meant
to augment the overall specificity using LPBE-HIS (Table 3).
The samples were first classified as negative by LPBE when
their titres were equal or below 1.6. Using this cut-off, only
10% of the samples were found to be false positives. The
samples with values above LPBE Log10 titre = 1.6 were retested
in the AE (Test 2) and classified as positive when the OD values
were above 0.7 (cut-off for best accuracy by ROC, Table 1). This
serial testing yielded an excellent specificity (Sp = 90.6) and a
very good sensitivity (Se = 87.9), and concordance with VNT
was moderate (κ = 0.76).
In a second exercise, we combined AE and IE, which can be
run simultaneously and in a single dilution. These tests had high
specificity but lacked sensitivity. Parallel testing aimed to
increase sensitivity implies to consider a sample as ‘positive’
when any of the tests or both give a positive result, and nega-
tive only when both give negative results. Serial testing using
one test to accept positives reduced the specificity to unaccep-
table levels (data not shown).
Based on frequency graphs, we considered that a first selec-
tion could be done with OD values from AE testing, considering
as negative samples those with OD values equal to or below
0.35, and as positive those over 1.1. Samples with ODs
between those values were reassessed by IE, with a cut-off of
1.1. Results (Table 2) show that in fact this combination
increased sensitivity to 94.8%, the highest value estimated so
far, while specificity was still acceptable (84.4%). This combined
testing yielded a strong concordance with the VNT titres (κ =
0.803). Thus, running a single plate containing serum samples
by these IEs, a strong concordance with VNT results can be
achieved, allowing an accurate surveillance of vaccine perform-
ance in the field using buffalo serum samples.
4. Discussion
An accurate assessment of herd immunity to estimate the
expected protection against FMDV is paramount for countries
undergoing compulsory vaccination programmes. Serology
studies measuring antibodies to structural proteins induced
by vaccines are not available for buffaloes; there is no infor-
mation about the protective VNT titres in this species, and
there is only one paper published in the 1990s (Araujo et al.
1996) analysing if LPBE titres match with those measured by
the VNT.
Here we tested 91 buffalo serum samples with different VNT
titres and compared the results with those obtained with tra-
ditional LPBE and two novel IEs. The currently used LPBEs are
performed either using monoclonal antibodies or hyperim-
mune sera as the detector antibodies. Our results show that
both assays perform equally with buffalo serum samples,
meaning that they will provide equivalent information as they
do with bovine samples. Only five samples were classified
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differently by these tests, considering their VNT titres as refer-
ence values.
Here we found that, unlike the results obtained with bovine
samples, anti-FMDV serum neutralizing titres did not match
those measured by the LPBEs. In fact, although sensitivity was
acceptable for this assay, specificity was low. Based on the lit-
erature, we cannot attribute this difference to an intrinsic per-
formance of the neutralization tests with buffalo antibodies.
Maddur et al. (2009) demonstrated that the kinetics of the
serum neutralizing antibody response to FMDV Asia 1 infection
in buffaloes was similar to that of cattle. Gomes et al. (1997) also
reported similarity in the kinetics of VNT titres in the sera of
FMDV type O-infected buffaloes and cattle. Our data show
that the lack of agreement between LPBEs and VNT is mainly
due to high LPBE titres achieved from serum samples with
low VNT titres. We speculate that the presence of low binders
capturing FMDV particles may account for this difference. A bio-
logic activity like virus neutralization (assessed by VNT) may be
more dependent on high-avidity antibody binding to the viral
particle. This same hypothesis can explain why the AE rendered
the highest specificity. From our data, we infer there might be
larger amount of low-avidity binders, such as low affinity
natural antibodies (Nab) (Casali & Notkins 1989) in buffalo
than in bovine sera. Nab have been found in cattle (Ploegaert
et al. 2011) and buffaloes (Matheswaran et al. 2003), and
although we could not find in the literature evidence on the
presence of higher levels of low affinity antibodies or B1 cells
in buffaloes compared to cattle, it has been previously
described that although buffaloes are susceptible to most of
the pathogens that affect cattle, diseases in these animals are
often less harmful (Yang et al. 2012; Reichel et al. 2015).
Using LPBE for testing a large number of samples is labour
intensive. With the purpose of providing a high-throughput,
low labour test, we developed two IEs using purified-inactivated
virus as capture antigen, which minimizes the presence of cross-
reactive binders as a strategy to improve specificity. These
assays avoid the need of developing coating and detector anti-
bodies for each particular strain and allow high-throughput
assessment as they are performed with a single dilution of
the sera, for detecting both total (IE) and high-avidity antibodies
(AE). AEs are usually used to discriminate between chronic and
acute infections, or as an alternative to neutralization assays,
among other applications (Thomas & Morgan-Capner 1988;
Enders & Knotek 1989; Schubert et al. 1998; Fox et al. 2006;
Hamkar et al. 2006; Franco Mahecha et al. 2011). This strategy
has been applied before to detach low binders and increase
the specificity of the ELISA applied for FMDV diagnosis in
cross-protection trials (Brito et al. 2014). In this study the AE
yielded high specificity (∼90%), although the sensitivity was
not good enough as to be used as a sole alternative assay to
the VNT.
Considering the different sensitivity and specificity of the
serological assays, we investigated if combining two tests in a
sequence-based analysis could render higher diagnostic
Figure 2. ROC curves were built for LPBE-His (A), LPBE-Mab (B), indirect ELISA ‘IE’ (C) and avidity ELISA ‘AE’ (D). Values for the AUC, standard error, CI and p-values are
shown for each individual curve.
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agreement with VNT. Using a simple serial testing approach by
running the highest sensitive ELISA (LPBE), accepting negatives
(low cut-off) and retesting positives with a highly specific assay
(AE) increased concordance with VNT to 76% and sensitivity to
88%. The best agreement values (κ = 80%) were obtained when
combining the results of both single-dilution ELISAs, meaning
that a single-dilution ELISA assay can produce similar diagnostic
results as VNT when using buffalo serum samples, with the
additional benefit of having a high-throughput reproducible
assessment that only takes a few hours of work to provide
the result.
The aim of this study was to evaluate the concordance
between VNT and ELISA results when using buffalo serum
samples; thus, the samples were classified according to their
VNT titre, without any further consideration. We have a
selection bias due to the compulsory vaccination campaign
applied in Argentina, as all non-vaccinated animals are
between 6 and 18 months old. Data from our laboratory and
others show that calves are immunologically identical to adult
animals at this age (Sadir et al. 1988; Spath et al. 1995; Buca-
fusco et al. 2014); thus, we do not expect an impact on antibody
titres due to this bias. We cannot rule out, however, the role of
IgMs, Nabs or high-affinity IgGs as a result of multiple vacci-
nations in the results obtained by either test.
Our results need to be confirmed and extended to more
samples and also using different vaccine preparations. Here
we tested only 91 samples against the O1/Campos vaccine
strain, selected due to the importance of serotype O in the
most recent outbreaks in the region and because O1/Campos
140S particles are the most unstable antigen in the current
Table 1. Concordance between VNT and the ELISAs.
Assay Specifications Readout Sensitivity Specificity κ value Level of agreement
LPBE-HIS Serial dilution liquid-phase blocking ELISA.
Uses HIS to reveal
Titre 84.2 (75.2–91.0) 48.4 (37.7–59.1) 0.34 Minimal
LPBE-Mab Serial dilution liquid-phase blocking ELISA.
Uses a mixture of Mab to reveal
84.6 (75.5–91.3) 48.6 (97.8–59.2) 0.35 Minimal
IE Single-dilution indirect ELISA OD value 71.2 (68.0–80.4) 84.4 (73.0–89.6) 0.51 Weak
AE Single-dilution indirect ELISA with a urea washing step 74.6 (64.5–83.3) 93.83 (85.0–98.8) 0.62 Weak
Notes: Analysis of sensitivity and specificity obtained by the different assays against O1/Campos exercised as a single test, and their concordance (Cohen’s Kappa, ‘κ’) to
VNT titres. Information on the type of technique has also been included. Values of 95% CI are indicated between brackets.
Table 2. Correlation between the different ELISAs and VNT.
Correlation analysis
Serological assay
LPBE-HIS LPBE-Mab AE IE
Pearson r 0.4582 0.44321 0.539 0.3998
95% confidence interval 0.3040–0.6347 0.2576–0.5972 0.3606–0.6684 0.1653–0.5350
P value <.0001 <.0001 <.0001 .0006
Notes: Pearson’s correlation analysis to quantify the association between the diagnostic results obtained by VNT and the different ELISAs.
Figure 3. The graphs depict the percentage of samples with VNT titres above or below the EPP-75% cut-off value within each range of values obtained by AE and IE (OD
values) or LPBE (titres). Arrows indicate the approximate position of the cut-off values used for each assay.
Table 3. The combined application of different ELISAs enables a high concordance with VNT results.
TEST 1 Conditions (test 1) TEST 2 Selection (test 2) Sensitivity Specificity K value (VNT) Level of agreement
LPBE Log10 titre≤ 1.6 - classify NEGATIVE
Log10 titre > 1.61: RETEST
AE Cut-off = 0.7 87.9 (0.80–0.93) 90.6 (0.84–0.96) 0.764 Moderate
AE OD < 0.35-classify NEGATIVE
OD≥ 1.1 Classify POSITIVE
0.35≤ OD < 1.1: RETEST
IE Cut-off = 1.1 94.8 (0.87–0.99) 84.4 (0. 87–0.91) 0.803 Strong
Notes: Results were obtained by applying sequential testing. These combinations entail evaluating serum samples using a first test (Test 1), applying certain conditions
and then assessing non-conclusive samples (‘RETEST samples’) by test 2 applying the selected cut-off. Values of 95% CI are indicated between brackets.
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vaccine formulation (Bucafusco et al. 2014). Preliminary data
from our laboratory show that the results are similar when
testing these samples with the different ELISAs against the
A24 Cruzeiro strain. This is expected as all the commercial vac-
cines produced in Argentina are controlled for antibody
responses against each vaccine strain, and differences in the
immune response induced by these strains in terms of total
and neutralizing antibodies have never been reported.
VNT tests are expensive; they require dedicated facilities and
manipulating live virus, which needs to be produced, titrated and
stored. Cell culture adds variability and contamination is always a
threat. About 40 serum samples can be run each time by one
trained operator, who will provide results supported by visual
reading not before than 48 h upon sample arrival. LPBE is a
great improvement to VNT, but relies on capture and detector
antibodies that need to be produced and standardized. The
novel IEs only use purified 140S particles. In our study, 30 ml of
a PEG-concentrated inactivated virus batch yielded about 2 mg
of purified 140S particles, which is enough for preparing 1000
plates; this means 40,0000 serum samples can be evaluated
with a single antigen batch. A trained operator can run up to
10 plates (400 samples) in half-day of work, producing results
that are objective and traceable.
This is the first study that analyses the diagnostic accuracy of
traditional and novel tests routinely utilized for the assessment
of antibodies against FMDV in buffaloes. The biological features
of the humoral responses in bubaline species may interfere with
the traditional ELISA tests, causing an inaccurate assessment of
the vaccine-induced antibody responses, especially due to
false-positive results. In this regard, the combination of two
single-dilution high-throughput ELISAs may afford a cheaper,
simpler and faster alternative to the VNT. Provided a thorough
validation is performed, these assays may be useful for monitor-
ing the effectiveness of vaccination campaigns in buffalo
populations.
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